-
ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED - Envision House, 5 North Street, Horsham, West Sussex, Grossbritannien
Firmenprofil
- Handelsregisternummer
- 10138701
- Firmenstatus
- EINGETRAGEN
- Land
- Grossbritannien
- Protokollierter Sitz
- Envision House
- 5 North Street
- Horsham
- West Sussex
- RH12 1XQ Envision House, 5 North Street, Horsham, West Sussex, RH12 1XQ UK
Management
- Geschäftsführung
- HOLLIS KORTH, Joshua
- MILLER III, Howard Collins
Firmendetails
- Geschäftszweig
- ltd
- Gründungsdatum
- 21.04.2016
- Alter der Firma 2016-04-21 8 Jahre
- SIC/NACE
- 74909
Eigentumsverhältnisse
- Beneficial Owners
- Envision Pharma Bidco Limited
Landes-Besonderheiten
- Firmenname (in Englisch)
- Alligent Biopharm Consulting (Europe) Limited
- Zusätzliche Statusdetails
- Active
- Ehemalige Namen
- TYROL ACQUISITIONCO LIMITED
- Bilanzhinterlegung
- Fälligkeit: 2024-09-30
- Letzte Einreichung: 2022-12-31
- Jahresmeldung
- Fälligkeit: 2025-05-04
- Letzte Einreichung: 2024-04-20
-
ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED Firmenbeschreibung
- ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED ist eine in Grossbritannien als ltd registrierte Firma mit der Register-Nr. 10138701. Ihr derzeitiger Status ist "eingetragen". Die Firma wurde 21.04.2016 registriert. ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED hat Ihre Tätigkeit zuvor unter dem Namen TYROL ACQUISITIONCO LIMITED ausgeführt. Das Unternehmen ist mit dem SIC/NACE Code "74909" registriert. Das Unternehmen hat 2 Geschäftsführer Die Bilanz wurde zuletzt am 31.12.2022 hinterlegt.Die Firma kann schriftlich über Envision House erreicht werden.
Jetzt sichern ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED HandelsregisterauszugJahresabschlussListe der GesellschafterGesellschaftsvertragBeneficial Owners Check
Sie befinden sich hier: Alligent Biopharm Consulting (Europe) Limited - Envision House, 5 North Street, Horsham, West Sussex, Grossbritannien
- 2016-04-21
- 0-2
- 3-5
- 6-20
- 21-50
- 51+
- Jahre
Haben Sie gewusst? kompany stellt Ihnen amtliche & offizielle Dokumente zu ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED aus Handelsregister und Firmenbuch im Original zur Verfügung. Das garantieren wir.
Handelsregisterauszug
Amtlicher Nachweis der Existenz des Unternehmens
Jahresabschluss
Finanzdaten zum letzten Berichtsjahr
Liste der Gesellschafter
Angaben zu den Eigentumsverhältnissen
Gesellschaftsvertrag
Gründungsdokumente
Beneficial Owners Check
Angaben über den wirtschaftlichen Eigentümer (Beneficial Owner)
Amtliche Dokumente
Amtliche Dokumente direkt vom offiziellen Handelsregister
keyboard_arrow_down 2024
-
change-to-a-person-with-significant-control (2024-04-22) - PSC05
-
change-person-director-company-with-change-date (2024-04-23) - CH01
-
confirmation-statement-with-no-updates (2024-04-25) - CS01
keyboard_arrow_right 2023
-
appoint-person-director-company-with-name-date (2023-09-27) - AP01
-
termination-director-company-with-name-termination-date (2023-09-26) - TM01
-
accounts-with-accounts-type-audit-exemption-subsiduary (2023-09-26) - AA
-
legacy (2023-09-26) - PARENT_ACC
-
legacy (2023-09-26) - AGREEMENT2
-
legacy (2023-09-26) - GUARANTEE2
-
confirmation-statement-with-updates (2023-04-26) - CS01
-
appoint-person-director-company-with-name-date (2023-03-22) - AP01
-
capital-allotment-shares (2023-02-24) - SH01
keyboard_arrow_right 2022
-
appoint-person-director-company-with-name-date (2022-01-11) - AP01
-
legacy (2022-09-21) - PARENT_ACC
-
legacy (2022-09-21) - AGREEMENT2
-
accounts-with-accounts-type-audit-exemption-subsiduary (2022-09-21) - AA
-
move-registers-to-sail-company-with-new-address (2022-06-27) - AD03
-
termination-director-company-with-name-termination-date (2022-01-12) - TM01
-
legacy (2022-09-21) - GUARANTEE2
-
legacy (2022-01-17) - GUARANTEE2
-
legacy (2022-01-17) - AGREEMENT2
-
legacy (2022-01-17) - PARENT_ACC
-
capital-allotment-shares (2022-04-26) - SH01
-
confirmation-statement-with-updates (2022-04-27) - CS01
-
change-sail-address-company-with-old-address-new-address (2022-06-27) - AD02
-
accounts-with-accounts-type-audit-exemption-subsiduary (2022-01-17) - AA
keyboard_arrow_right 2021
-
confirmation-statement-with-updates (2021-05-26) - CS01
-
termination-director-company-with-name-termination-date (2021-09-24) - TM01
keyboard_arrow_right 2020
-
accounts-with-accounts-type-audit-exemption-subsiduary (2020-10-03) - AA
-
legacy (2020-10-03) - PARENT_ACC
-
legacy (2020-10-03) - GUARANTEE2
-
legacy (2020-10-03) - AGREEMENT2
-
appoint-person-director-company-with-name-date (2020-11-19) - AP01
-
confirmation-statement-with-updates (2020-04-30) - CS01
-
mortgage-create-with-deed-with-charge-number-charge-creation-date (2020-11-10) - MR01
-
mortgage-create-with-deed-with-charge-number-charge-creation-date (2020-11-12) - MR01
-
termination-director-company-with-name-termination-date (2020-11-26) - TM01
-
capital-allotment-shares (2020-11-24) - SH01
keyboard_arrow_right 2019
-
confirmation-statement-with-no-updates (2019-05-01) - CS01
-
capital-allotment-shares (2019-06-21) - SH01
-
legacy (2019-07-12) - GUARANTEE2
-
legacy (2019-07-12) - AGREEMENT2
-
legacy (2019-07-12) - PARENT_ACC
-
accounts-with-accounts-type-audit-exemption-subsiduary (2019-07-12) - AA
keyboard_arrow_right 2018
-
legacy (2018-10-05) - PARENT_ACC
-
legacy (2018-09-24) - AGREEMENT2
-
legacy (2018-09-24) - GUARANTEE2
-
confirmation-statement-with-no-updates (2018-05-15) - CS01
-
accounts-with-accounts-type-audit-exemption-subsiduary (2018-10-05) - AA
-
termination-director-company-with-name-termination-date (2018-12-13) - TM01
-
appoint-person-director-company-with-name-date (2018-12-13) - AP01
keyboard_arrow_right 2017
-
change-sail-address-company-with-new-address (2017-04-27) - AD02
-
accounts-with-accounts-type-audit-exemption-subsiduary (2017-10-10) - AA
-
legacy (2017-10-10) - PARENT_ACC
-
legacy (2017-10-10) - GUARANTEE2
-
legacy (2017-10-10) - AGREEMENT2
-
resolution (2017-03-02) - RESOLUTIONS
-
change-person-director-company-with-change-date (2017-03-02) - CH01
-
confirmation-statement-with-updates (2017-05-04) - CS01
-
move-registers-to-sail-company-with-new-address (2017-04-27) - AD03
keyboard_arrow_right 2016
-
incorporation-company (2016-04-21) - NEWINC
-
capital-redomination-of-shares (2016-06-06) - SH14
-
capital-allotment-shares (2016-09-13) - SH01
-
appoint-person-director-company-with-name-date (2016-07-20) - AP01
-
change-registered-office-address-company-with-date-old-address-new-address (2016-07-20) - AD01
-
mortgage-create-with-deed-with-charge-number-charge-creation-date (2016-07-05) - MR01
-
legacy (2016-06-06) - SH20
-
change-account-reference-date-company-current-shortened (2016-04-21) - AA01
-
legacy (2016-06-06) - CAP-SS
-
resolution (2016-06-06) - RESOLUTIONS
-
capital-statement-capital-company-with-date-currency-figure (2016-06-06) - SH19